Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06376110 · ClinicalTrials.gov registry record · NA
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
A NA study of Acne, sponsored by Austin Institute for Clinical Research.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06376110 is a NA study of Acne that is actively recruiting participants, run by Austin Institute for Clinical Research. The registered enrollment target is 10 participants, below the 142-participant average among 26 other Acne trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06376110, a NA study of Acne, is actively recruiting participants, sponsored by Austin Institute for Clinical Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a split-face, single-blind study assessing the use of an antioxidant serum with a series of acne laser treatments to reduce sebum production in healthy male and female subjects between the ages of 18 and 65 years, inclusive, with Fitzpatrick skin types I-VI.
Conditions Studied
Interventions
- DRUG Topical Antioxidant Serum
- DEVICE AviClear Laser
Study Locations (1)
Texas
- Austin Institute for Clinical Research, Inc. - Pflugerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-04-24 |
| Est. Completion | 2025-04-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06376110
The ClinicalTrials.gov registry entry for NCT06376110 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 142-participant average among 26 other Acne trials with a reported enrollment target (93% lower). The listed sponsor is Austin Institute for Clinical Research, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acne appearing as the primary indexed condition, and to 2 interventions - of which Topical Antioxidant Serum is the first listed.
NCT06376110 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06376110 about?
NCT06376110 is a clinical study titled "Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production". This is a split-face, single-blind study assessing the use of an antioxidant serum with a series of acne laser treatments to reduce sebum production in healthy male and female subjects between the ages of 18 and 65 years, inclusive, with Fitzpatrick skin types I-VI.
What is the current status of trial NCT06376110?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-04-24. Estimated completion is 2025-04-24.
What conditions does trial NCT06376110 study?
This clinical trial studies the following conditions: Acne.
What interventions are being tested in trial NCT06376110?
The interventions under investigation include: Topical Antioxidant Serum (DRUG), AviClear Laser (DEVICE).
Who is sponsoring clinical trial NCT06376110?
This trial is sponsored by Austin Institute for Clinical Research, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06376110 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AVAVA MIRIA General Use
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
-
The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation
COMPLETED · NA
-
An Exploratory Investigation of a Male Focused Skincare Supplement
COMPLETED · NA
-
An Exploratory Investigation of a Novel Skincare Regimen
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.